<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-21T11:36:27+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【一周君】七款新药，可直接提上市申请；两种情况，临床期间即可申请批准；德琪医药健之佳上市启动...</title>
    <updated>2020-11-20T18:01:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/TsiuMD-3tMegnhMlncjCCg</id>
    <link href="https://mp.weixin.qq.com/s/TsiuMD-3tMegnhMlncjCCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】7款注射剂过评已满3家！50亿级大品种再通过；扬子江、先声、科伦...</title>
    <updated>2020-11-20T18:01:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/_9XVZGafA2OGyX-zZfIprA</id>
    <link href="https://mp.weixin.qq.com/s/_9XVZGafA2OGyX-zZfIprA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3万起家，他靠「眼睛」获2600亿市值，成湖南首富！</title>
    <updated>2020-11-20T18:01:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/WE9vugp9UDBXQilWAaIK-w</id>
    <link href="https://mp.weixin.qq.com/s/WE9vugp9UDBXQilWAaIK-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国家医保局公布DIP病种目录名单</title>
    <updated>2020-11-20T18:01:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/FvDd1tJqEZmrEb8Ncfnf-A</id>
    <link href="https://mp.weixin.qq.com/s/FvDd1tJqEZmrEb8Ncfnf-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚通报！国内新增4例本土病例，已有医院被封控</title>
    <updated>2020-11-20T18:01:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/8rZkel2hsSctxdZMGvq6fQ</id>
    <link href="https://mp.weixin.qq.com/s/8rZkel2hsSctxdZMGvq6fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>100亿市场震荡！首个国产ALK抑制剂获批上市；多家企业布局，正大天晴、齐鲁、复星...</title>
    <updated>2020-11-19T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/kd8nEwXmwtJBmcBZ74684Q</id>
    <link href="https://mp.weixin.qq.com/s/kd8nEwXmwtJBmcBZ74684Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>索格列净治疗心衰结果重磅发布！SGLT2抑制剂还有多少惊喜？</title>
    <updated>2020-11-19T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/KrV73ZnK8K8KjbyqFRazZw</id>
    <link href="https://mp.weixin.qq.com/s/KrV73ZnK8K8KjbyqFRazZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CRO迎来最大跌停，真的是&#34;MAH制度&#34;与“CRO”掐架导致的？</title>
    <updated>2020-11-19T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/Ai5H9J9mUVSQnbaANyS16Q</id>
    <link href="https://mp.weixin.qq.com/s/Ai5H9J9mUVSQnbaANyS16Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局：这3类药品省级可增补</title>
    <updated>2020-11-19T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/qbkUsRQmtcp_UXq_xDYbyA</id>
    <link href="https://mp.weixin.qq.com/s/qbkUsRQmtcp_UXq_xDYbyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GLP-1类药物搅局500亿“糖尿病”市场，通化东宝、甘李药业“危矣”</title>
    <updated>2020-11-18T17:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/XOAvGr_uDCa3FY8AeW9SWw</id>
    <link href="https://mp.weixin.qq.com/s/XOAvGr_uDCa3FY8AeW9SWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从服务实验室到3千亿医药航母，李革和他的CRO王国</title>
    <updated>2020-11-18T17:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/f8DWyhzSazgto6MJgdNA6w</id>
    <link href="https://mp.weixin.qq.com/s/f8DWyhzSazgto6MJgdNA6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA发表声明，维护COVID-19 EUA的透明度</title>
    <updated>2020-11-18T17:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/DBqC8bFjIvHGZ995RbDAHg</id>
    <link href="https://mp.weixin.qq.com/s/DBqC8bFjIvHGZ995RbDAHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国家基药目录调整最新会议结果流出！</title>
    <updated>2020-11-18T17:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/wybanmZ9qdHP1r9K5uHxlg</id>
    <link href="https://mp.weixin.qq.com/s/wybanmZ9qdHP1r9K5uHxlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌突破！溶瘤病毒联手CAR-T，疗效1+1&gt;2？</title>
    <updated>2020-11-17T17:50:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/rU9lroJ1z7U1837kpjy8vg</id>
    <link href="https://mp.weixin.qq.com/s/rU9lroJ1z7U1837kpjy8vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有效性94.5%，年产10亿剂！mRNA 疫苗间的较量开始了</title>
    <updated>2020-11-17T17:50:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/k8ZIG3tQnQ56hdw42Xncuw</id>
    <link href="https://mp.weixin.qq.com/s/k8ZIG3tQnQ56hdw42Xncuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家卫健委谈综合医改！建立试点省份评估和动态调整机制</title>
    <updated>2020-11-17T17:50:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/lA0GB_b3DTDzkqThlgu4rw</id>
    <link href="https://mp.weixin.qq.com/s/lA0GB_b3DTDzkqThlgu4rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11个集采扩围品种，山西开始续约了！</title>
    <updated>2020-11-17T17:50:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/y9Bzfmaisy_0yoNDEbSS3g</id>
    <link href="https://mp.weixin.qq.com/s/y9Bzfmaisy_0yoNDEbSS3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有医药人，被驱逐行业10年</title>
    <updated>2020-11-17T17:50:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/2lHaNPVqZNExrS9VGDgpJg</id>
    <link href="https://mp.weixin.qq.com/s/2lHaNPVqZNExrS9VGDgpJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>读懂外媒眼中最受关注的10大中国Biotech公司！</title>
    <updated>2020-11-16T18:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/pCucz52SbKsMQfThBAEH2A</id>
    <link href="https://mp.weixin.qq.com/s/pCucz52SbKsMQfThBAEH2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州拟科创板IPO，Q3 PD-1卖了3.3 亿元，能否顺利进入医保目录？</title>
    <updated>2020-11-16T18:08:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/xlakL4fiYa4gYBMqueqkwQ</id>
    <link href="https://mp.weixin.qq.com/s/xlakL4fiYa4gYBMqueqkwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>